Nordwand Advisors, LLC Johnson & Johnson Transaction History
Nordwand Advisors, LLC
- $374 Billion
- Q3 2024
A detailed history of Nordwand Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Nordwand Advisors, LLC holds 763,062 shares of JNJ stock, worth $122 Million. This represents 33.1% of its overall portfolio holdings.
Number of Shares
763,062
Previous 331,934
129.88%
Holding current value
$122 Million
Previous $48.5 Billion
154.89%
% of portfolio
33.1%
Previous 21.16%
Shares
7 transactions
Others Institutions Holding JNJ
# of Institutions
4,219Shares Held
1.7BCall Options Held
12.5MPut Options Held
10.3M-
Vanguard Group Inc Valley Forge, PA229MShares$36.7 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY198MShares$31.7 Billion0.67% of portfolio
-
State Street Corp Boston, MA133MShares$21.3 Billion0.86% of portfolio
-
Geode Capital Management, LLC Boston, MA55.1MShares$8.82 Billion0.72% of portfolio
-
Morgan Stanley New York, NY42.1MShares$6.74 Billion0.48% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $419B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...